Sickle Cell Disease - Stroke Prevention in Nigeria Trial

计划入组 29 人 · 首次发布于 2013 年 2 月 28 日

A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

计划入组 500 人 · 首次发布于 2024 年 9 月 23 日

Improving Management and Secondary Prevention Through Azithromycin Comparative Trial in Rheumatic Heart Disease in Nigeria)- IMPACT-RHD Nigeria

计划入组 474 人 · 首次发布于 2026 年 6 月 4 日

4-azidocytidine analogs (Alios BioPharma/Centers for Disease Control and Prevention)

EV71 Vaccine(Jiangsu Province Centers for Disease Control and Prevention)

Yersinia pestis vaccine (Jiangsu Provincial Center for Disease Control and Prevention)

Jiangsu Provincial Center For Disease Control And Prevention

Jiangsu Province Centers for Disease Control and Prevention

People's Republic of China

CDC ENTEBBE

Uganda

Nigeria Advances Lassa Fever Vaccine Development with $250M CEPI Investment and Multi-Country Trials

Beyer Family Initiative Boosts Skin Cancer Prevention and Research in South Florida

NAIP Breaks Ground on State-of-the-Art Pharmaceutical Research Centre in Nigeria's Anambra State